Ned Milenkovich, PharmD, JD
This article is not intended as legal advice and should not be used as such. When legal questions arise, pharmacists should consult with attorneys familiar with the relevant drug and pharmacy laws. Ned Milenkovich is chair of the Healthcare Law practice at Much Shelist PC and vice chair of the Illinois State Board of Pharmacy. Contact him at: 312-521-2482 / [email protected]
OIG further restricts charitable copay assistance programs
The Supplemental Bulletin expands upon previous guidance, focusing particularly on disease funds and legitimate copay waivers for prescribed medications.
340B contract pharmacy arrangements
Pharmacies that want to keep their 340B Medicaid contracts had better police themselves for compliance irregularities and prepare for increased audits and oversight.
New Orleans pharmacy history highlights licensure requirement
Pharmacies often overlook their licensing requirements or fail to discover the extent to which a license is required for a particular activity. Not good.
Federal judge slams secrecy of compounding pharmacies
As opposition to execution drugs grows, manufacturers are cutting off supplies and compounding pharmacies are under pressure.
CMS changes attitude toward Part D plan arrangements
CMS is proposing a modified interpretation of the existing non-interference provisions that would remove any limitation on CMS’ regulation of the relationship between pharmacies and plan sponsors.
Physician in-office dispensing of Rx drugs
Any physician office that dispenses medications should be informed about its state's legal/regulatory obligations.
.pharmacy domain name passes initial ICANN evaluation
NABP effort seeks worldwide protection for consumers and users of pharmacies online.
California governor vetoes biosimilar substitution bill
With pharmacy industry bodies, labor unions, and special interest groups arrayed against the bill, Governor Brown returned the legislation to the State Senate unsigned.
Federal track and trace legislation imminent
The bicameral legislation provides specific requirements for all stakeholders in the drug-distribution supply chain, including manufacturers, wholesalers, repackagers, and pharmacies.
Refill reminder programs in jeopardy
With its interpretation, HHS effectively eliminated approximately $1.50 per reminder in payments made to pharmacies by drug manufacturers.